About EXBIO Antibodies
Founded in 1990 as a spin-out from the Czech Academy of Sciences, EXBIO develops monoclonal antibodies and flow cytometry reagents for research and clinical applications. The company specialises in the analysis of human cellular markers, with particular expertise in multicolour flow cytometry. Its technologies enable researchers to characterise immune cell populations, investigate disease mechanisms and support cellular phenotyping studies. EXBIO’s portfolio serves applications across immunology, haematology, oncology, stem cell research and cell biology. The company also maintains quality systems aligned with ISO 13485, ISO 9001 and cGMP requirements.
EXBIO offers more than 4,000 products, including monoclonal antibodies, fluorochrome-conjugated antibodies, recombinant proteins, immunoassays, cell viability reagents and flow cytometry kits. Its product range includes the DryFlowEx® family of diagnostic and research assays, multicolour antibody cocktails, sample preparation reagents and customised flow cytometry solutions. These products support workflows such as immune monitoring, lymphocyte subset analysis, PNH testing, basophil activation studies and other analytical cytometry applications. Following the acquisition of Apronex, the company also expanded capabilities in recombinant protein technologies and allergy-related assays.